OBI Pharma, Inc. (TPEX:4174)
Taiwan
· Delayed Price · Currency is TWD 37.95
-0.40 (-1.04%)
May 14, 2025, 1:30 PM CST
OBI Pharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 604.28 | 1,732 | 899.28 | 4,741 | 2,512 | 3,338 | Upgrade
|
| Short-Term Investments | 1,849 | 1,399 | 1,883 | 30.71 | 140 | - | Upgrade
|
| Trading Asset Securities | - | 0.09 | 0.23 | 0.75 | 1.77 | 383.53 | Upgrade
|
| Cash & Short-Term Investments | 2,453 | 3,131 | 2,782 | 4,773 | 2,654 | 3,722 | Upgrade
|
| Cash Growth | 3.28% | 12.53% | -41.70% | 79.83% | -28.69% | -23.44% | Upgrade
|
| Accounts Receivable | 4.87 | 4.2 | 6.48 | 2.04 | 3.47 | 1.45 | Upgrade
|
| Other Receivables | 22.54 | 19.01 | 30.82 | 26.24 | 19.8 | 17.57 | Upgrade
|
| Receivables | 27.41 | 23.21 | 37.29 | 28.27 | 23.27 | 19.02 | Upgrade
|
| Inventory | 30.83 | 27.73 | 25.93 | 21.97 | 9.56 | 7.36 | Upgrade
|
| Prepaid Expenses | - | 258.01 | 221.43 | 211.26 | 167.35 | 146.6 | Upgrade
|
| Other Current Assets | 256.96 | - | 100.34 | - | - | - | Upgrade
|
| Total Current Assets | 2,768 | 3,440 | 3,167 | 5,034 | 2,854 | 3,895 | Upgrade
|
| Property, Plant & Equipment | 1,118 | 1,165 | 1,249 | 1,176 | 1,149 | 918.22 | Upgrade
|
| Long-Term Investments | 917.99 | 959.85 | 1,070 | 8.73 | 9.11 | 8.04 | Upgrade
|
| Goodwill | - | - | - | 61.15 | 61.15 | 61.15 | Upgrade
|
| Other Intangible Assets | 60.24 | 62.84 | 73.18 | 321.29 | 337.14 | 392.73 | Upgrade
|
| Other Long-Term Assets | 30.03 | 26.13 | 51.64 | 32.9 | 76.21 | 64.9 | Upgrade
|
| Total Assets | 4,894 | 5,654 | 5,611 | 6,634 | 4,487 | 5,340 | Upgrade
|
| Accounts Payable | 1.82 | 3.44 | 0.77 | 1.14 | 0.53 | 0.16 | Upgrade
|
| Accrued Expenses | - | 251.9 | 65.76 | 112.49 | 177.82 | 67.69 | Upgrade
|
| Short-Term Debt | 25.57 | 0.41 | 4.31 | 15.71 | - | 9.47 | Upgrade
|
| Current Portion of Long-Term Debt | - | 34.09 | 7 | 7 | 7 | 9 | Upgrade
|
| Current Portion of Leases | 55.58 | 55.12 | 49.86 | 40.35 | 52.07 | 37.08 | Upgrade
|
| Current Income Taxes Payable | 9.98 | 10.39 | 1.58 | 0.56 | 0.34 | 1.11 | Upgrade
|
| Current Unearned Revenue | 5.41 | 7.78 | 6.29 | 3.16 | - | - | Upgrade
|
| Other Current Liabilities | 120.7 | 49.24 | 30.28 | 40.73 | 89.47 | 123.98 | Upgrade
|
| Total Current Liabilities | 219.07 | 412.37 | 165.84 | 221.14 | 327.22 | 248.49 | Upgrade
|
| Long-Term Debt | 39.7 | 48.22 | 60.06 | 67.07 | 28 | 35 | Upgrade
|
| Long-Term Leases | 352.92 | 366.79 | 425.89 | 163.03 | 205.96 | 155.41 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 46.33 | 54.76 | 63.2 | Upgrade
|
| Other Long-Term Liabilities | 6.04 | 6.01 | 5.89 | 0 | - | - | Upgrade
|
| Total Liabilities | 617.73 | 833.39 | 657.67 | 497.57 | 615.95 | 502.09 | Upgrade
|
| Common Stock | 2,632 | 2,632 | 2,294 | 2,294 | 1,993 | 1,993 | Upgrade
|
| Additional Paid-In Capital | 9,102 | 9,101 | 7,128 | 6,933 | 3,702 | 3,685 | Upgrade
|
| Retained Earnings | -8,391 | -7,879 | -5,569 | -4,523 | -2,909 | -1,378 | Upgrade
|
| Treasury Stock | -26.53 | -26.53 | -26.53 | -45.99 | -45.99 | -53.83 | Upgrade
|
| Comprehensive Income & Other | -10.37 | -12.09 | -19.87 | -26.32 | -24.53 | -16.79 | Upgrade
|
| Total Common Equity | 3,306 | 3,815 | 3,807 | 4,632 | 2,716 | 4,229 | Upgrade
|
| Minority Interest | 970.07 | 1,006 | 1,147 | 1,504 | 1,155 | 608.74 | Upgrade
|
| Shareholders' Equity | 4,276 | 4,820 | 4,953 | 6,136 | 3,871 | 4,838 | Upgrade
|
| Total Liabilities & Equity | 4,894 | 5,654 | 5,611 | 6,634 | 4,487 | 5,340 | Upgrade
|
| Total Debt | 473.77 | 504.63 | 547.11 | 293.15 | 293.03 | 245.95 | Upgrade
|
| Net Cash (Debt) | 1,979 | 2,626 | 2,235 | 4,479 | 2,361 | 3,476 | Upgrade
|
| Net Cash Growth | 8.62% | 17.49% | -50.10% | 89.73% | -32.08% | -24.19% | Upgrade
|
| Net Cash Per Share | 8.18 | 11.24 | 9.76 | 20.17 | 11.87 | 17.50 | Upgrade
|
| Filing Date Shares Outstanding | 262.33 | 262.97 | 229.25 | 229.11 | 198.95 | 198.89 | Upgrade
|
| Total Common Shares Outstanding | 262.33 | 262.97 | 229.25 | 229.11 | 198.95 | 198.89 | Upgrade
|
| Working Capital | 2,549 | 3,027 | 3,001 | 4,813 | 2,527 | 3,646 | Upgrade
|
| Book Value Per Share | 12.60 | 14.51 | 16.61 | 20.22 | 13.65 | 21.26 | Upgrade
|
| Tangible Book Value | 3,246 | 3,752 | 3,734 | 4,250 | 2,318 | 3,775 | Upgrade
|
| Tangible Book Value Per Share | 12.37 | 14.27 | 16.29 | 18.55 | 11.65 | 18.98 | Upgrade
|
| Land | - | - | - | 87.51 | 87.51 | 87.51 | Upgrade
|
| Buildings | - | 344.49 | 343.2 | 370.02 | 329.28 | 328.66 | Upgrade
|
| Machinery | - | 1,080 | 1,022 | 1,054 | 671.26 | 695.35 | Upgrade
|
| Construction In Progress | - | 10.07 | 66.46 | 35.74 | 368.45 | 117.37 | Upgrade
|
| Leasehold Improvements | - | 276.85 | 181.24 | 184.06 | 65.85 | 73.74 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.